Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.

Eur J Clin Pharmacol · 2012 · PMC3438395 · PMID 22457015

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

As a result of this negative trend, placebo-adjusted mean percentage change in SBP for the clevidipine dose groups shows a positive trend 6 and 8 h after cessation of clevidipine infusion (Fig. 2 c).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.